Clinical courses of TCR-WT-11-E04 and TCR-WT-06-E03 after the WT-specific TCR-T cell transfer. (A) The patient received 2 cycles of the TCR–T-cell therapy, and the second infusion was followed by 2 doses of WT1 peptide vaccination. One month after the second cycle, peripheral blood cell counts increased in association with a decrease in bone marrow blast counts. The patient did not require further red blood cell transfusion. (B) The patient received 2 cycles of the TCR-T cell therapy, and the second infusion was followed by 2 doses of WT1 peptide vaccination. After the second cycle, peripheral blood cell counts increased in association with decreased blast counts in bone marrow. Hb, hemoglobin; neut., neutrophil; Plt, platelet; RBC, red blood cell; WBC, white blood cell.